Group 1 - The fifth Brain Science Frontier and Industry Conference and the 2025 Shenzhen Brain-Computer Interface Expo were held in Shenzhen from December 28 to 30 [1] - The first national "Technology for Good Initiative for Brain Science and Brain-Computer Interface Development" was announced, aiming to promote collaboration between academia and industry [1] - The "Guangdong-Hong Kong-Macao Greater Bay Area AI Innovation Alliance for Brain Science and Central Nervous System Diseases" was launched to focus on drug innovation, brain-computer interfaces, and AI health applications [1] Group 2 - A total of 1.16 billion yuan industry fund for brain science was established, with initial quality projects signed on-site [1] - The "Shenzhen Zhongjin Brain Science and Brain-like Intelligence Private Equity Investment Fund" and "Shenzhen Blue Ocean Smart Brain Seed Fund" were launched to support the brain science and brain-computer interface industry [1] - A "Heart and Brain Health Innovation Governance Demonstration Street" was initiated in collaboration with various institutions [1][2] Group 3 - Shenzhen University of Technology and Shenzhen Brain Science Society reached a strategic cooperation to cultivate innovative talents in the Greater Bay Area [2] - New branches for brain-computer interfaces and mental health were established under the Shenzhen Brain Science Society [2] - The 2025 Shenzhen Brain Expo was co-hosted by multiple institutions, including the Shenzhen Brain Science Society and the Chinese Neuroscience Society [2]

Core Insights - The main goal of the "14th Five-Year Plan" is to significantly enhance the level of "self-reliance and strength in technology," focusing on rapid breakthroughs in key core technologies and increasing the number of leading fields [1][2] - Despite continuous growth in R&D investment, China's basic research proportion remains lower than that of developed countries, highlighting the need for original innovation and tackling key core technology challenges [1][2] - The financing difficulties faced by original innovation and key core technology projects are becoming increasingly prominent, necessitating the establishment of a suitable technology finance support system during the "14th Five-Year Plan" period [1][2] R&D Investment Trends - From 2016 to 2022, global R&D expenditure as a percentage of GDP increased by 0.51 percentage points for the world, 0.45 for China, 0.75 for the U.S., and 1.22 for South Korea, indicating a significant upward trend [2] - China's global innovation index ranking improved from 34th in 2012 to 11th in 2024, making it the only middle-income economy in the top 30 [2] Challenges in Financing - Original innovation projects typically exhibit high risk, high investment, and long cycles, which conflict with traditional financial institutions' preference for stability and short-term returns [3] - Financial institutions face challenges in assessing the value of technology due to the unique nature of original innovation and key core technology paths, making traditional risk assessment models inadequate [4][5] - There is a structural contradiction in the funding supply, with government-guided funds favoring later-stage projects, resulting in low investment rates for early-stage projects [3][5] Proposed Solutions - Experts suggest constructing a multi-layered, full-cycle technology finance support system to address the complex financing challenges [5][6] - Recommendations include improving the supply of innovative financing tools, enhancing the knowledge property pledge financing mechanism, and expanding pilot programs for "investment-loan linkage" [5][6] - Financial institutions are encouraged to develop differentiated products such as R&D loans and talent loans, and to strengthen data sharing between government, banks, and enterprises [6][7]